Caricamento...
Sustained Neurological Recovery after Stroke in Aged Rats Treated with a Novel Prostacyclin Analog
BACKGROUND AND PURPOSE: Targeting the prostacyclin/IP receptor to reduce stroke injury has been hindered by the lack of selective drugs. MRE-269 is the active metabolite of selexipag showing a very high selectivity toward the IP receptor. Selexipag has been recently approved for clinical use in pulm...
Salvato in:
| Pubblicato in: | Stroke |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5508605/ https://ncbi.nlm.nih.gov/pubmed/28588054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.016474 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|